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Cushing’s syndrome can present with a spectrum of symptoms; however, it is less recognised that psychiatric
symptoms can form part of the clinical presenting features. In the investigations for an organic cause for a
psychiatric illness, Cushing’s syndrome needs to be considered, especially if there are other features such as
hirsutism or hypertension. In this article, the two cases reported demonstrate that a prompt diagnosis is not only
important for psychiatric management but also crucial for timely institution of the necessary treatment of life-
threatening causes of hypercortisolaemia such as metastatic adrenal carcinoma.
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Endogenous Cushing’s syndrome results from chronic ex-
cess glucocorticoid production from the adrenal glands. It
may be adrenocorticotropic hormone (ACTH) dependent
(80%–85%) or independent (15%–20%). ACTH dependent
causes include, most commonly, a pituitary corticotrophic
adenoma (Cushing’s disease), less frequently, an extra-
pituitary tumour (ectopic ACTH syndrome) and rarely a
tumour secreting corticotropin-releasing hormone (CRH).
ACTH independent causes are from unilateral adre-
nocortical tumours, which can be benign or malignant, or
bilateral adrenal hyperplasia [1].
Hyper-vigilance is necessary because patients can
present with features that can be nonspecific and insidi-
ous in development, and the disease activity can vary
over time. The non-psychiatric clinical features of
Cushing’s syndrome can include central adiposity, pro-
ximal myopathy, thin skin, purple striae on the trunk,
scalp hair loss, fatigue, hypertension, glucose intolerance,
acne, hirsutism and menstrual irregularity. The clinical
features of Cushing’s syndrome can also be typical of other
common disorders such as the metabolic syndrome, with
insulin resistance, and polycystic ovary syndrome.* Correspondence: a.osullivan@unsw.edu.au
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reproduction in any medium, provided the orDepression, mood dysregulation, sleep disturbance and
cognitive abnormalities are also observed in Cushing’s
syndrome [1]. The rates for each of these symptoms vary
widely across studies. Depression is the most prevalent
psychiatric disturbance in Cushing’s syndrome. A major
depressive syndrome is seen in 50%–70% of the cases [2].
Other associated features include anxiety in 12%–79% of
the cases [3], as well as a rate of 3% for hypomania [4].
Less common are features of psychosis and mania [5,6].
Reassessment of some of these patients after the re-
duction of cortisol levels showed a reduced rate of psy-
chiatric diagnoses, with improvements in depression,
anxiety, somatic symptoms and neuroticism scores [4].
Another prospective study of 33 patients with active
Cushing’s syndrome showed that 67% had psychopath-
ology before cure. Of these, 52% had atypical depressive
disorder and 12% had major depressive disorder. One year
post-cure, overall psychopathology improved to 24% of
the subjects with atypical depressive disorder remaining
the most common diagnosis [7]. The authors report that
a premorbid or concurrent psychiatric diagnosis with
Cushing’s syndrome did not influence the incidence of
psychopathology after the correction for high cortisol
levels [7]. Some patients have been reported to have
residual psychiatric symptoms and cognitive deficits
long after the cure of Cushing’s syndrome [1].
Conceptual models have been reported to try to explain
glucocorticoid actions in the brain. Psychiatric features of
Cushing’s syndrome are associated with increased netd. This is an Open Access article distributed under the terms of the Creative
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It has also been suggested that the memory deficits are re-
lated to dysfunction of the neocortex and hippocampus,
areas with high density of glucocorticoid receptors. Inter-
estingly, the hypotheses relating to hypercortisolaemia
associated with depression are less straight forward. Here,
the glucocorticoid signalling insufficiency hypothesis sug-
gests that hypercortisolaemia is an attempt to overcome
primary glucocorticoid receptor resistance related to
down-regulated glucocorticoid receptors. In contrast, the
glucocorticoid signalling overactivity hypothesis for de-
pression suggests there is overall increased net signalling
via the glucocorticoid receptor. Changes in cortisol activity
leading to decreased serotonin and increased dopamine
cerebral activity have also been described [8].
Evaluation of patients with suspected Cushing’s syn-
drome can be complex and involvement of an endocrin-
ologist is recommended. Initial screening tests include
more than one elevated 24-h urinary free cortisol level
and/or lack of cortisol suppression after low-dose dexa-
methasone testing. Once hypercortisolaemia is confirmed,
ACTH levels, CRH stimulation test, high-dose dexa-
methasone test and imaging may be considered to differ-
entiate whether the source may be adrenal, pituitary or
ectopic [1]. However, it needs to be considered that a
primary psychiatric condition may be associated with
increased cortisol levels, so false positive findings need to
be excluded.
In the present article, we report two cases of psychosis,
which were the presenting features of Cushing’s syndrome,
suggesting that clinicians should be mindful that Cushing’s
syndrome could be a cause of psychiatric symptoms.
Psychiatric symptoms may be the original presentation
and the diagnosis can easily be missed without a high
index of suspicion. Psychiatric symptoms can potentially
be refractory to psychotropic medications with untreated
hypercortisolaemia, and the underlying cause can have a
high mortality and morbidity if left unrecognised.
Case presentations
Case report 1
A 46-year-old Asian woman presented to the hospital with
major depression with psychotic features, manifesting as
auditory hallucinations, depressed mood, anxiety and
somatic complaints. This presentation was on a back-
ground of polypharmacy overdose 2 months earlier with-
out suicidal intent. There was a gradual decline in the
mental state since that discharge. She was non-adherent
to olanzapine and citalopram, and previous investigations
during recent multiple hospital admissions had not found
an organic cause for her psychiatric presentation.
Upon investigations for complaints of headache and
chest pains, she was found to have had developed hyper-
tension and hypokalaemia (potassium 2.4 mmol/L). Shewas also noted to have a cushingoid appearance. Cushing’s
syndrome was confirmed with an elevated serum cortisol
858 nmol/L (normal range 155–599 nmol/L) and urinary
free cortisol >999 nmol/24 h (normal range 50–170 nmol/
day). These findings were confirmed on repeat testing with
serum cortisol of 836 nmol/L and urine free cortisol
441 nmol/24 h despite incompletion of the urine speci-
men. Serum ACTH was suppressed on both occasions
(<5 pg/mL) indicating a primary adrenal cause.
Abdominal computed tomography (CT) scan with
contrast showed an irregular 3-cm left adrenal lesion
with reported low density and no enhancement with
contrast. Markedly increased glucose metabolism in the
left adrenal gland was found, consistent with a high
grade tumour, on fluorodeoxyglucose positron emission
tomography/computed tomography (FDG PET/CT) whole
body scanning. No other sites of disease were found. Her
plasma aldosterone to renin ratio and catecholamines
were normal excluding primary hyperaldosteronism and
phaeochromocytoma.
She underwent a laparoscopic left adrenalectomy with
perioperative hydrocortisone cover. The histological ap-
pearance was consistent with an adrenal cortical aden-
oma. A synacthen test 4 days post-operatively showed
persistent adrenal insufficiency due to suppression of the
right adrenal gland activity, therefore requiring ongoing
prednisone replacement therapy which was withdrawn
over the next few months.
By discharge, she had been stabilised with aripiprazole
20 mg mane and mirtazapine 30 mg nocte. By 6 weeks
post surgery, her psychosis had resolved and her
cushingoid features showed improvement. By 6 months
post surgery, she had been weaned off her psychotropic
medications and antihypertensive medications, and her
mental state and blood pressure were normal.
Case report 2
A 25-year-old Caucasian woman presented to the hospital
with 6 days of psychotic symptoms on a background of no
previous psychiatric diagnosis. In the immediate pre-
hospitalisation period, she presented primarily with a
depressive syndrome with psychotic features (auditory
hallucinations and nihilistic delusions). Furthermore, in
that previous 6 months, she had suffered a myriad of other
symptoms including insomnia, weight loss, virilising fea-
tures (hirsutism, facial acne and scalp hair loss) and other
cushingoid features. A provisional diagnosis of psychosis
secondary to a general medical condition was made.
Investigations revealed hypercortisolaemia (serum cor-
tisol 1,225 nmol/L), and ACTH-independent Cushing’s
syndrome was confirmed with a persistently elevated cor-
tisol (1,040 nmol/L) with ACTH suppression (1 pg/mL).
Ultrasound, CT and magnetic resonance imaging (MRI)
showed an 11-cm left necrotic adrenal cortical tumour
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Left upper quandrantectomy (splenectomy, nephrectomy,
adrenalectomy and distal pancreatectomy) was performed.
Adrenal and liver histology confirmed adrenal cortical
carcinoma with local infiltration and distant metastasis.
In the first instance, her psychotropics were quetiapine
and venlafaxine. Pre-operatively, her hypercortisolaemia
was treated with metyrapone (adrenocorticoid synthesis
inhibitor) and mitotane (adrenolytic compound). She con-
tinued on low-dose prednisone post-operatively because
of partial suppression of the contra-lateral adrenal gland
from long-standing endogenous hypercortisolaemia and
hypothalamic-pituitary axis suppression.
Post-operatively, the patient went into a catatonic state
which lasted a total of 2 weeks. It was characterised by, at
various times, immobility, mutism, persecutory delusions
and other psychotic features, automatic obedience, staring,
impulsivity and waxy flexibility. There was gradual re-
sponse to the cessation of quetiapine and venlafaxine
and to the use of lorazepam (oral/intravenous). With
the resolution of the catatonia, she was found to have
an underlying depressive syndrome with psychotic fea-
tures. The above catatonia initially persisted despite
normalisation of her serum cortisol (135 nmol/L) and
plasma ACTH (8 pg/mL). Other medical causes of cata-
tonia were further excluded with appropriate blood and
normal cerebrospinal fluid analyses and cerebral MRI.
At the time of discharge, her psychotic symptoms had
resolved and her mood had greatly improved. She was
discharged with medications risperidone, modified-release
venlafaxine and reducing dose of lorazepam. Psychiatric
follow-up was arranged. Unfortunately, 2 months after
surgery, during evaluation for adjuvant radiotherapy, she
was found to have recurrent hepatic metastasis that re-
quired chemotherapy.Conclusions
In the present article, we present a case of acute-on-
chronic psychotic depression associated with Cushing’s
syndrome from an adrenal adenoma and another case
of psychosis secondary to Cushing’s syndrome from a
metastatic adrenal carcinoma. In both cases, the diagno-
sis of Cushing’s syndrome was only made when mental
disturbance had escalated requiring further medical
attention. These cases highlight the importance of the
consideration of Cushing’s syndrome as a differential
diagnosis when ruling out medical causes in patients
with either new or persistent mental disturbance. The
physical and biochemical features associated with
Cushing’s syndrome can be varied and subtle at times.
Early recognition and timely institution of appropriate
management can minimise significant morbidity and
mortality.Consent
Written informed consent was obtained from the patients
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